FDA — authorised 3 July 1992
- Application: NDA019697
- Marketing authorisation holder: JANSSEN PHARMS
- Local brand name: ORTHO TRI-CYCLEN
- Indication: TABLET — ORAL-21
- Status: approved
FDA authorised Ortho Tri Cyclen on 3 July 1992
Yes. FDA authorised it on 3 July 1992.
JANSSEN PHARMS holds the US marketing authorisation.